内科学
脂肪变性
内分泌学
脂肪细胞
细胞外
脂肪组织
生物
化学
医学
脂肪肝
肥胖
脂肪变
细胞外基质
胰岛素抵抗
拉顿
瘦素
细胞内
作者
Tian Zhang,Longkun Hu,Chen Diao,Yongxin Chen,Fei Zhou,Ruohan Lou,Yuxia Zhou,Yuanyuan Wang,Mingjun Shi,Ke‐Gang Linghu,Ligen Lin,Bing Guo
标识
DOI:10.1038/s41467-026-71731-2
摘要
Adipose tissue dysfunction drives hepatic lipid overload in metabolic dysfunction-associated steatotic liver disease (MASLD), yet the involvement of adipose tissue-derived small extracellular vesicles (sEVs) remains unclear. Herein, we showed that transplanting adipose tissue from high‑fat diet (HFD)-fed male mice exacerbated insulin resistance and hepatic steatosis in lean recipients. Adipose‑specific Sirt3 overexpression (Sirt3AKI) alleviated insulin resistance and liver steatosis in HFD-fed male mice, whereas adipose‑specific Sirt3 knockdown aggravated these phenotypes. Moreover, adipose sEV miRNAs regulated hepatic lipid metabolism in Sirt3AKI male mice. MicroRNA sequencing identified miR-30a-3p was increased in the circulating sEVs from HFD-fed male mice, while decreased in sEVs from Sirt3OE adipocytes and Sirt3AKI male mice. Mechanistically, miR‑30a‑3p promoted hepatic steatosis by targeting Becn1; this process was suppressed when Sirt3 downregulated miR‑30a‑3p transcription via deacetylation of H3K56. These findings highlight the critical role of adipose sEV microRNAs in driving hepatocyte lipotoxicity, and suggest miR-30a-3p inhibition as a promising MASLD therapy. The authors highlight the role of miR-30a-3p from adipocyte small extracellular vesicle in driving hepatocyte lipotoxicity in metabolic dysfunction-associated steatotic liver disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI